Skip to content


Suma Vupputuri, PhD, MPH, FAHA

Research Scientist


PhD, Tulane University School of Public Health and Tropical Medicine, 2001
MPH, Tulane University School of Public Health and Tropical Medicine, 1996

Suma Vupputuri is an epidemiologist with a focus on the etiology, prevention, and treatment of chronic disease. Her substantive areas of interest include heart disease, diabetes, and chronic kidney disease epidemiology, as well as health services and health disparities research. Dr. Vupputuri has worked at Kaiser Permanente for over 10 years in both the Mid-Atlantic and Georgia regions and has experience with many types of study designs including observational, qualitative, pragmatic trials, and multi-site surveillance/data systems.

Dr. Vupputuri has worked in a variety of different health research settings and has broad experience on how real-world health data is collected, managed, and processed in and across different systems. Her goal is to apply her research interests and experiences with “big data” to novel and exciting studies that will ultimately lead to better health outcomes for patients at KPMAS.

Dr. Vupputuri is an elected Fellow of the American Heart Association (FAHA) conferred by the Council on Epidemiology and Prevention and recognized for her excellence and sustained contributions to scholarship, practice, education, and volunteer service within in the American Heart Association. She has 20+ years of research experience; has published over 80 manuscripts in peer-reviewed journals; and served as PI/site-PI/co-PI on more than 30 funded studies.

Research Interests:

Chronic disease epidemiology (cardiovascular disease, diabetes, chronic kidney disease), health services, health disparities, comparative effectiveness, medication adherence, quality of care issues

For a full list of publications, please see Dr. Vupputuri’s Curriculum Vitae.

  1. Pampati S, Dana Flanders W, Zhang Q, Ahmedani BK, Bhasin S, Getahun D, Lash TL, McCracken C, Sandberg DE, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. “Prevalence of self-inflicted injuries among transgender and gender diverse adolescents and young adults compared to their peers: an examination of interaction with mental health morbidity.” Ann Epidemiol. 2023 May;81:40-46.e2.
  2. Genelin MP, Helmkamp LJ, Steiner JF, Maertens JA, Hanratty R, Vupputuri S, Havranek EP, Dickinson LM, Blair IV, Daugherty SL. “Patient Pill Organization Strategies and Adherence Measured in a Cross-Sectional Study of Hypertension.” Patient Prefer Adherence 2023 Mar 23;17:817-826.
  3. Rahman VJ, Horberg MA, Hu H, Vupputuri S. Implementation of a Plant-Based, Nutrition Program in a Large Integrated Health Care System: Results of a Pilot Program. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211053198.
  4. Wagner S, Panagiotakopoulos L, Nash R, Bradlyn A, Getahun D, Lash TL, Roblin D, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. Progression of Gender Dysphoria in Children and Adolescents: A Longitudinal Study. Pediatrics. 2021 Jul;148(1):e2020027722.
  5. Zhang Q, Rechler W, Bradlyn A, Flanders WD, Getahun D, Lash TL, McCracken C, Nash R, Panagiotakopoulos L, Roblin D, Sandberg DE, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. Changes in Size and Demographic Composition of Transgender and Gender Non-Binary Population Receiving Care at Integrated Health Systems. Endocr Pract. 2021 May;27(5):390-395.
  6. Vupputuri S, Daugherty S, Yu K, Derus AJ, Wells A, Truong C, Singh T, Emanuel EW. The Quality of Transgender Patient Care: Results from Patient Focus Groups and Electronic Medical Record Data. Healthcare (Basel). 2021 May 2;9(5):530.
  7. Panagiotakopoulos L, Wagner S, Nash R, Bradlyn AS, Getahun DT, Lash TL, Roblin DW, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. Pathway from Gender Diverse Behavior to Gender Dysphoria-Related Diagnosis and Hormone Therapy. Pediatrics. 2021 Jul;148(1):e2020027722.
  8. Hashemi L, Zhang Q, Getahun D, Jasuja GK, McCracken C, Pisegna J, Roblin D, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M. Longitudinal changes in Liver Enzyme Levels among Transgender People Receiving Gender Affirming Hormone Therapy. J Sex Med. 2021 Sep;18(9):1662-1675.
  9. Kaplan RM, Martin K, Tanaka Y, Passman RS, Fine M, Rasmussen-Torvik LJ, Vupputuri S, Khan SS. Efficacy and Safety of Direct Oral Anticoagulant Use for Atrial Fibrillation Across Body Mass Index Categories. J Am Heart Assoc. 2020 Dec 15;9(24):e017383.
  10. Vupputuri S, Daugherty S, Yu K, Truong C, Wells A, Emanuel EW. The quality of care of transgender and gender nonconforming patients: The provider perspective. Perm J. 2020;25:19.227.
  11. Bavishi A, Bruce M, Hongyan N, Mehta PP, Glynn P, Ahmad FS, Yancy CW, Shah SJ, Allen NB, Vupputuri S, Rasmussen-Torvik LJ, Lloyd-Jones DM, Khan SS. Predictive Accuracy of Heart Failure-Specific Risk Equations in an Electronic Health Record-Based Cohort. Circ Heart Fail. 2020 Nov;13(11):e007462. Epub 2020 Oct 23.
  12. Rethy L, McCabe M, Pool L, Vu TH, Kershaw K, Yancy C, Vupputuri S, Feinglass J, and Khan S. Contemporary Rates of Hospitalization for Heart Failure in Young and Middle-Aged Adults in a Diverse US State. Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e007014. Epub 2020 Nov 12.
  13. Kamineni A, Vupputuri S. Challenges to Evaluating Diversity and Inclusion in Scientific Communities (Letter). Am J Epidemiol. 2020 Oct 1;189(10):1210.
  14. To M, Zhang Q, Bradlyn A, Getahun D, Giammattei S, Nash R, Owen-Smith A, Roblin D, Silverberg M, Tangpricha V, Vupputuri S, Goodman M. Visual Conformity with Gender Identity: Its Distribution and Association with Depression and Anxiety in a Cohort of Transgender People. J Sex Med. 2020 Oct;17(10):2084-2092. Epub 2020 Aug 15.
  15. Mak J, Shires DA, Prieto L, Ahmedani BK, Becerra-Culqui TA, Bradlyn A, Flanders WD, Getahun D, Giammattei SV, Hunkeler E, Lash TL, Millman A, Nash R, Quinn VP, Robinson B, Roblin D, Silverberg MJ, Slovis J, Tangpricha V, Vupputuri S, Goodman M. Incidence and Determinants of Suicide Attempts in a Cohort of Transgender and Gender Non-Conforming People. Am J Prev Med. 2020 Oct;59(4):570-577.
  1. Social Determinants of Health and Racial/Ethnic Disparities (SO HEARD) in Hypertension, Diabetes, and Chronic Kidney Disease
    The overall goal of this project is to conduct an in-depth assessment of racial/ethic differences in hypertension, diabetes, and chronic kidney disease by disentangling the relationship between social determinants of health and race/ethnicity.
    Social Needs Network for Evaluation and Translation
    Role: Co-Primary Investigator
  2. Impact of Coronavirus Disease 2019 on Cardiovascular Care: Collateral Damage from a Pandemic
    This study examines characteristics of the COVID-19 patient population and factors associated with mortality especially in high-risk subgroups.  Further the project assesses trends in cardiovascular hospitalization rates prior to and during the COVID-19 pandemic.
    Garfield Memorial Fund
    Role: Co-Primary Investigator
  3. Cohort Study of Patients with Disorder of Sex Development (DSD)
    The goal of this study is to f=develop and validate an electronic health record-based cohort of patients with DSD, across 3 large health systems and describe clinical characteristic and pathways of care.  We will also compare DSD quality of care indicators against actual DSD management delivered.
    Co-Investigator/Site Primary Investigator
  4. Using Values Affirmation to Reduce the Effects of Perceived Discrimination on Hypertension Disparities
    This pragmatic trail examines the effect of intervening on perceived stereotype threat on hypertension management by testing a values affirmation intervention, across 3 diverse health systems.  The primary outcome is change in adherence to antihypertensive therapies with the secondary outcome of change in blood pressure.
    Co-Investigator/Site Primary Investigator
  5. HbA1c Variability and Health Outcomes Among Patients with Diabetes
    Goal: The purpose of this study is to develop a new quality measure for patients with diabetes, beyond just HbA1c alone, to better identify those at risk for diabetes complications and mortality.
    Site Primary Investigator
  1. July 2018, Invited speaker/panelist: “Advocating for Ourselves” PCORI-funded workshop engaging the transgender community with researchers. (George Washington University, Patient-Centered Initiatives & Health Equity)
  2. June 2018, Oral scientific presentation: American Diabetes Association 78th Scientific Sessions, Orlando, FL “Cumulative Delays in Treatment Intensification over Three Typical Stages of Anti-Hyperglycemic Treatment.”
  3. January 2015, Invited presentation: Kaiser Permanente Mid-Atlantic States, Mid-Atlantic Permanente Research Institute, Rockville, MD. “Big Data and Chronic Disease Research.”
  4. May 2013, Speaker/Host: Health Authority of Abu Dhabi, Department of Chronic Diseases, Abu Dhabi, UAE. “Asthma Guidelines Training Workshop” (Continuing Medical Education Workshop: 6.25 CME credits, 100 participants).
  5. April/May 2013, Speaker/Host: Health Authority of Abu Dhabi, Section of Cardiovascular and Metabolic Disorders, Abu Dhabi, UAE. “Training Workshop on the Weqaya Screening Programme” (Training of Weqaya facility clinicians and staff, 30 participants).
  6. March 2013, Guest speaker: Diabetes Complications Continuing Medical Education (CME) Workshop, Abu Dhabi, UAE. (Workshop sponsored by Pfizer).
  7. November 2012, Guest speaker: Health Authority of Abu Dhabi, Department of Cardiovascular and Metabolic Disorders, Abu Dhabi, UAE. “Training Workshop on the Weqaya Cardiovascular Screening Programme” (Training of Weqaya facilities).
Back To Top